ATE170513T1 - Diastereomeres salz von optisch aktiver chinolinmevalonsäure - Google Patents

Diastereomeres salz von optisch aktiver chinolinmevalonsäure

Info

Publication number
ATE170513T1
ATE170513T1 AT92110636T AT92110636T ATE170513T1 AT E170513 T1 ATE170513 T1 AT E170513T1 AT 92110636 T AT92110636 T AT 92110636T AT 92110636 T AT92110636 T AT 92110636T AT E170513 T1 ATE170513 T1 AT E170513T1
Authority
AT
Austria
Prior art keywords
optically active
diastereomeric salt
quinolinemevalonic acid
active quinolinemevalonic
acid
Prior art date
Application number
AT92110636T
Other languages
German (de)
English (en)
Inventor
Yoshio Ohara
Mikio Suzuki
Yoshinobu Yanagawa
Hiroshi Iwasaki
Nobuhide Miyachi
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE170513T1 publication Critical patent/ATE170513T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT92110636T 1991-06-24 1992-06-24 Diastereomeres salz von optisch aktiver chinolinmevalonsäure ATE170513T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15181091 1991-06-24
JP12727792A JP3528186B2 (ja) 1991-06-24 1992-05-20 光学活性キノリンメバロン酸のジアステレオマー塩

Publications (1)

Publication Number Publication Date
ATE170513T1 true ATE170513T1 (de) 1998-09-15

Family

ID=26463266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92110636T ATE170513T1 (de) 1991-06-24 1992-06-24 Diastereomeres salz von optisch aktiver chinolinmevalonsäure

Country Status (10)

Country Link
US (3) US5284953A (enExample)
EP (2) EP0520406B1 (enExample)
JP (1) JP3528186B2 (enExample)
KR (1) KR100208867B1 (enExample)
AT (1) ATE170513T1 (enExample)
CA (1) CA2072162C (enExample)
DE (1) DE69226822T2 (enExample)
DK (1) DK0520406T3 (enExample)
ES (1) ES2120973T3 (enExample)
TW (1) TW293007B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1136183C (zh) * 1994-02-25 2004-01-28 代科化学工业株式会社 光学活性甲羟戊酸内酯类化合物的制造方法
BR9609872A (pt) 1995-07-17 1999-03-23 Warner Lambert Co Hemi sal de cálcio de ácido (R-(R*R*)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino
DK0814782T3 (da) * 1995-12-22 2002-12-16 Nissan Chemical Ind Ltd Farmaceutisk præparat stabiliseret med et basisk middel
GB9614804D0 (en) * 1996-07-15 1996-09-04 Chiroscience Ltd Resolution process
AU755543B2 (en) * 1997-12-19 2002-12-12 Warner-Lambert Export Limited Process for the synthesis of 1,3-diols
PT1099694E (pt) 1998-07-23 2005-10-31 Nissan Chemical Ind Ltd Processo para a preparacao de um derivado de quinolina e um intermediario para esse fim
KR100311645B1 (ko) * 1999-12-24 2001-10-12 이홍천 간판
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
AU2002241271B2 (en) * 2001-04-05 2007-01-25 Nissan Chemical Industries, Ltd. Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
JP4783998B2 (ja) * 2001-05-15 2011-09-28 宇部興産株式会社 (3r,5s)−7−置換−3,5−ジヒドロキシヘプト−6−エン酸の製法
WO2003027073A1 (fr) * 2001-09-19 2003-04-03 Ube Industries, Ltd. Procede de production d'ester optiquement actif d'acide 7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoique
US6835838B2 (en) * 2002-01-28 2004-12-28 Novartis Ag Process for the manufacture of organic compounds
DE60326819D1 (de) 2002-01-31 2009-05-07 Novartis Ag Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
ZA200502325B (en) 2002-09-20 2006-11-29 Nissan Chemical Ind Ltd Method for producing a 3,5-dihydroxy-6-heptenoate
WO2004072040A1 (en) * 2003-02-12 2004-08-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of pitavastatin calcium
EP1614429A4 (en) * 2003-04-17 2007-05-02 Kowa Co LKLF / KLF2 GEN-EXPRESSIONSPROMOTER
WO2005077916A1 (en) * 2004-01-19 2005-08-25 Ranbaxy Laboratories Limited Salts of hmg-coa reductase inhibitors and use thereof
JP2007512347A (ja) * 2003-11-26 2007-05-17 デューク・ユニバーシティー 緑内障を予防するかまたは治療する方法
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN101220021B (zh) * 2007-01-12 2010-12-08 上海医药工业研究院 4-取代苯氧基喹啉类化合物及其中间体、制备方法和应用
WO2008111055A1 (en) * 2007-03-12 2008-09-18 In-Dot Ltd. Color sensing for a reader device and the like
WO2010027060A1 (ja) * 2008-09-05 2010-03-11 日産化学工業株式会社 3,5-ジヒドロキシ-6-ヘプテン酸アミン塩類の製造方法
US20120022102A1 (en) 2010-01-20 2012-01-26 Cadila Healthcare Limited Method for preparation of pitavastatin and its pharmaceutical acceptable salts thereof
JP2013536219A (ja) 2010-08-25 2013-09-19 カディラ・ヘルスケア・リミテッド ピタバスタチンカルシウムおよびその調製方法
WO2012063254A1 (en) * 2010-11-12 2012-05-18 Hetero Research Foundation Novel polymorphs of pitavastatin calcium
KR101270586B1 (ko) * 2010-11-26 2013-06-03 주식회사 아미노로직스 광학적으로 순수한 2,2'-디히드록시-1,1'-바이나프틸-3-카르복실산의 제조방법
WO2012140490A2 (en) 2011-04-11 2012-10-18 Aurobindo Pharma Limited Process for preparing quinoline derivative
JP2011173912A (ja) * 2011-04-28 2011-09-08 Ube Industries Ltd (3r,5s)−7−置換−3,5−ジヒドロキシヘプト−6−エン酸の製法
WO2013037838A1 (en) 2011-09-12 2013-03-21 Farma Grs, D.O.O. Polymorphic form of pitavastatin calcium
JP2013103884A (ja) * 2011-11-10 2013-05-30 Daito Kk ピタバスタチンカルシウム塩の工業的製造方法
CN102653523A (zh) * 2011-12-17 2012-09-05 东莞达信生物技术有限公司 一种匹伐他汀钙重结晶制取方法
WO2013098773A1 (en) * 2011-12-28 2013-07-04 Dr. Reddy's Laboratories Limited Crystalline forms of pitavastatin calcium
CN102653524A (zh) * 2012-01-12 2012-09-05 东莞达信生物技术有限公司 一种匹伐他汀钙中间体的制备方法
EP2978743B1 (en) * 2013-03-29 2019-11-27 Centrient Pharmaceuticals Netherlands B.V. Amine salts of pravastatin and rosuvastatin
MX2015013696A (es) * 2013-03-29 2016-02-26 Dsm Sinochem Pharm Nl Bv Sales de amina de pitavastatina y rosuvastatina.
CN103508949B (zh) * 2013-10-22 2015-12-09 黄河三角洲京博化工研究院有限公司 一种(e)-3-[2-环丙基-4-(4-氟-苯基)-3-喹啉基]丙烯醛的合成方法
WO2016056658A1 (ja) * 2014-10-10 2016-04-14 株式会社エーピーアイ コーポレーション スタチン系化合物の精製方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH576447A5 (enExample) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
DE3905908A1 (de) 1989-02-25 1990-09-06 Bayer Ag Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
DE3925636A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Imino-substituierte pyridine
EP0430129A3 (en) * 1989-11-30 1992-02-26 Tanabe Seiyaku Co., Ltd. Novel phenylethylene derivatives, processes for preparing the same and intermediates therefor
JPH054943A (ja) * 1990-08-30 1993-01-14 Sagami Chem Res Center 光学活性β,δ−ジケト酸エステル及びその還元体

Also Published As

Publication number Publication date
CA2072162A1 (en) 1992-12-25
EP0742209A3 (en) 1997-05-14
EP0520406A1 (en) 1992-12-30
DK0520406T3 (da) 1998-12-14
TW293007B (enExample) 1996-12-11
KR100208867B1 (ko) 1999-07-15
EP0520406B1 (en) 1998-09-02
US5473075A (en) 1995-12-05
JPH05148237A (ja) 1993-06-15
JP3528186B2 (ja) 2004-05-17
KR930000486A (ko) 1993-01-15
US5284953A (en) 1994-02-08
CA2072162C (en) 2002-11-19
EP0742209A2 (en) 1996-11-13
DE69226822T2 (de) 1999-02-11
DE69226822D1 (de) 1998-10-08
US5514804A (en) 1996-05-07
ES2120973T3 (es) 1998-11-16

Similar Documents

Publication Publication Date Title
DE69226822D1 (de) Diastereomeres Salz von optisch aktiver Chinolinmevalonsäure
NO178969C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner
PT90377A (pt) Processo para a preparacao de derivados do acido piridonocarboxilico com actividade optica
FI101226B1 (fi) Menetelmä lääkeaineena käyttökelpoisten 2-[2-(karbonyyli)pyrrolidin-4-yylitio]-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi
DE69328962D1 (de) Verfahren zur herstellng von cyano-methoxyiminomethylderivaten
NO175529C (no) Fremgangsmåte for rensing av tryptofan
DK0501774T3 (da) Fremstilling af substituerede tetrahydropyridiner
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
UA8357A1 (uk) Спосіб оптичного поділу піранобензоксадіазольної сполуки
DE69218414D1 (de) Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
DE69133494D1 (de) Microbiologische Herstellung von L-Ascorbinsäure
DE69833951D1 (de) Verfahren zur herstellung von substituierten alkylaminen oder salzen davon
EP0608693A3 (de) Verfahren zur Herstellung von Folsäure.
DE3889772D1 (de) Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden.
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
DK0488345T3 (da) Optisk aktive 1,4-dihydropyridinderivater og fremgangsmåder til fremstilling deraf
DE59206973D1 (de) Trocknungsverfahren zur Herstellung von Ascorbinsäure-2-Monophosphaten
DE3887465D1 (de) Verfahren zur Herstellung von Säureanhydriden.
ATE92500T1 (de) Methode zur herstellung von indan-derivaten.
BR9405262A (pt) Processo para a preparação de um ácido piridina-2,3-dicarboxílico
DE2967648D1 (en) Utilisation of 2-(n-(2,6-dichloro-phenyl)-n-allyl-amino)-imidazoline-(2) for the production of bradycardiac drugs
ES2195309T3 (es) Derivados de tetrahidrofurano.
IT1224527B (it) Solfonati di 2,3-epossialchilammonio otticamente attivi, procedimento per la loro produzione, erelativo impiego
ATE197949T1 (de) Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür
ES2085540T3 (es) 2-(3-fenilpropil)hidrazinas, productos intermedios en y un procedimiento para la preparacion de las mismas, y su uso como medicamentos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification